Mallinckrodt Plc Ordinary Share (MNK) 97.84 $MNK
Endo and BioDelivery Sciences submit NDA for transmucosal pain med
Seeking Alpha - at Seeking Alpha - Thu Dec 25, 11:41AM CST
MNK: 97.84 (-0.29), BDSI: 12.65 (+0.66), ENDP: 72.10 (+0.34), EGLT: 5.97 (+0.21), ZGNX: 1.20 (+0.04), PFE: 31.42 (-0.03), TEVA: 57.09 (+0.33), ABBV: 66.21 (+1.86), ALKS: 56.16 (+1.02), ACUR: 0.52 (+0.02)
Insider Trading Alert - FNGN, PGR And MNK Traded By Insiders
at The Street - Wed Dec 24, 10:33AM CST
Stocks with insider trader activity include FNGN, PGR and MNK
MNK: 97.84 (-0.29), PGR: 26.92 (-0.05), FNGN: 37.85 (+0.79)
Mallinckrodt to Present at J.P. Morgan Healthcare Conference January 12
Business Wire - Mon Dec 22, 4:00PM CST
Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, will present at the 33rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis on Union Square in San Francisco on Monday, January 12, 2015. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 3 p.m. Pacific/6 p.m. Eastern.
MNK: 97.84 (-0.29), JPM: 62.48 (unch)
5 Health Care Stocks John Paulson Is Buying Ahead of 2015
at The Street - Mon Dec 22, 6:00AM CST
Here's a closer look at five stocks Paulson & Co. bought in the most recently reported quarter.
MNK: 97.84 (-0.29), HCA: 74.89 (-0.11), COV: 103.35 (+0.57), MYL: 56.97 (+0.39), ABBV: 66.21 (+1.86)
Baidu, Alibaba Among Top World Stocks Building Bases
at Investor's Business Daily - Thu Dec 18, 5:09PM CST
This is the time when investors should be building watch lists, and the Top World Stocks list offers a range of possible candidates. Three stocks on the list (to the right), Avago Technologies (AVGO), Cimpress (CMPR) and Radware (RDWR), are clearly...
MNK: 97.84 (-0.29), RDWR: 22.18 (+0.24), ACT: 254.20 (-1.68), BIDU: 230.98 (-2.18), HDB: 50.86 (-0.06), CMPR: 75.76 (+0.05), NXPI: 76.75 (+0.48), AVGO: 100.72 (-0.06), BABA: 105.95 (+0.43)
Great Stocks: Mallinckrodt Rebounds, But Is It A Buy?
at Investor's Business Daily - Thu Dec 18, 5:09PM CST
Specialty drugmaker Mallinckrodt (MNK) has rebounded off its 10-week moving average for the third time since it broke out of a cup base in early September. But should investors buy the bounce? Mallinckrodt cleared an 83.30 cup-base buy point Sept. 3...
MNK: 97.84 (-0.29), COV: 103.35 (+0.57)
Top Healthcare Stocks for 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 14, 10:03AM CST
Source: Flickr user Tax Credits . This past year has been a great one for healthcare investors -- the S&P healthcare index ETF offered double the return of the S&P 500. Biotechnology stocks dominated the list of the 10 top-performing...
MNK: 97.84 (-0.29), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), AGN: 210.12 (+0.95), VRTX: 115.15 (+1.40), ALNY: 93.52 (+0.97), EW: 130.75 (+1.17), ILMN: 186.22 (+2.72), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07), PBYI: 189.96 (+0.12)
Top Global Stocks: Jazz, Actavis In IBD's World List
at Investor's Business Daily - Mon Dec 08, 5:39PM CST
Three top-ranked drugmakers are among IBD's 10 leading global growth stocks. One is in buying range. Jazz Pharmaceuticals (JAZZ) appears to have gained some traction after a disappointing breakout Nov. 5, when the stock cleared its buy point only to...
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31), ACT: 254.20 (-1.68), COV: 103.35 (+0.57), JAZZ: 165.33 (+1.83)
Great Stocks: Mallinckrodt Buys Raise Profit Margins
at Investor's Business Daily - Thu Dec 04, 5:20PM CST
Mallinckrodt has been active in its brief run as a public company. The specialty pharmaceuticals firm debuted in July 2013 after being spun off from Covidien (COV). Two major acquisitions -- Questcore Pharmaceuticals, finalized in August, and Cadence...
MNK: 97.84 (-0.29), ACT: 254.20 (-1.68), COV: 103.35 (+0.57)
Pain Therapeutics' Remoxy Would Be A Good Fit For Any Of These Experienced Companies
Clinically Sound Investor - at Seeking Alpha - Wed Dec 03, 2:41PM CST
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31), ENDP: 72.10 (+0.34), ACT: 254.20 (-1.68), DRRX: 0.81 (-0.01), NVS: 93.91 (+0.66), PTIE: 2.01 (-0.02)
Mallinckrodt to Present at Piper Jaffray 26th Annual Healthcare Conference in New York
Business Wire - Mon Dec 01, 3:45PM CST
Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical and global medical imaging company, will present at the Piper Jaffray 26th Annual Healthcare Conference in New York on Wednesday, December 3, 2014. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 11 a.m. Eastern.
MNK: 97.84 (-0.29)
Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Mallinckrodt, and Actavis
PR Newswire - Tue Nov 25, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), Zoetis Inc. (NYSE: ZTS), Allergan Inc. (NYSE: AGN), Mallinckrodt PLC (NYSE: MNK), and Actavis PLC (NYSE: ACT). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 24, 2014, the NASDAQ Composite ended at 4,754.89, up 0.89%, the Dow Jones Industrial Average advanced 0.04%, to finish the day at 17,817.90, and the S&P 500 closed at 2,069.41, up 0.29%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 792.85, up 0.47%, with the index also advancing 9.00% in the previous three months. Register for your complimentary reports on these five stocks at:
MNK: 97.84 (-0.29), AGN: 210.12 (+0.95), ZTS: 43.84 (+0.87), ACT: 254.20 (-1.68), AVNR: 16.91 (+0.01)
Alibaba: The Top New Position For Hedge Funds
ValueWalk - at Seeking Alpha - Fri Nov 21, 2:24PM CST
MNK: 97.84 (-0.29), EBAY: 57.10 (-0.12), SHPG: 209.29 (+0.07), ABBV: 66.21 (+1.86), AAPL: 112.01 (-0.53), BABA: 105.95 (+0.43)
10 Stocks Billionaire John Paulson Loves in 2014
at The Street - Fri Nov 21, 7:56AM CST
Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.
MNK: 97.84 (-0.29), HCA: 74.89 (-0.11), EQIX: 233.16 (+1.18), SHPG: 209.29 (+0.07), COV: 103.35 (+0.57), DTV: 86.82 (-0.05), MYL: 56.97 (+0.39), ABBV: 66.21 (+1.86), TWC: 151.15 (+0.17), CIE: 8.79 (-0.25)
FDA clears Purdue's abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 12:36PM CST
MNK: 97.84 (-0.29), EGLT: 5.97 (+0.21), ZGNX: 1.20 (+0.04), PFE: 31.42 (-0.03), TEVA: 57.09 (+0.33), ABBV: 66.21 (+1.86), ALKS: 56.16 (+1.02), ACUR: 0.52 (+0.02)
Tracking John Paulson's Paulson & Company Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Thu Nov 20, 12:49AM CST
RKT: 61.26 (-0.41), KOG: 6.56 (-0.39), MEAS: 86.00 (+0.01), HHC: 133.21 (+0.49), AET: 89.59 (+0.14), DLPH: 73.45 (-0.42), DLTR: 69.86 (-0.20), AEM: 23.65 (+0.65), AUXL: 34.40 (+0.18), DG: 69.86 (+0.31), ABBV: 66.21 (+1.86), DXM: 9.06 (+0.12), MNK: 97.84 (-0.29), ATHL: 58.40 (unch), NCQ: 0.55 (unch), COV: 103.35 (+0.57), AU: 8.39 (+0.24), MYL: 56.97 (+0.39), IAG: 2.41 (+0.06), FDO: 79.14 (-0.01), MGM: 20.77 (-0.17), GNW: 8.40 (+0.01), HIG: 42.13 (-0.12), NG: 2.82 (+0.10), EQIX: 233.16 (+1.18), HSH: 62.96 (unch), OAS: 16.66 (-1.05), PETM: 81.16 (+0.03), ACT: 254.20 (-1.68), MDT: 74.08 (+0.31), BPOP: 33.68 (+0.09), ENZY: 7.48 (-0.01), FCX: 22.91 (+0.07), GFI: 4.37 (+0.13), CZR: 15.44 (+0.20), CVC: 20.60 (+0.17), CIE: 8.79 (-0.25), CACQ: 9.96 (+0.12), AGN: 210.12 (+0.95), ECA: 13.73 (-0.03), FCH: 10.80 (-0.06), R: 93.37 (-0.15), DTV: 86.82 (-0.05), KMDA: 3.57 (-0.03), ANV: 0.88 (+0.02), MOVE: 20.95 (-0.03), BAC: 17.98 (+0.05), GRFS: 34.26 (+0.33), POST: 42.51 (+0.49), HCA: 74.89 (-0.11), RDN: 16.78 (+0.18), BEE: 13.55 (-0.01), CPWR: 10.35 (+0.01), GLD: 112.77 (+0.03), RLGY: 43.91 (+0.39), MTG: 9.31 (+0.06), HMHC: 20.75 (-0.03), CMCSA: 58.07 (+0.17), CBS: 55.70 (-0.13), BABA: 105.95 (+0.43)
Mallinckrodt tops, no outlook
at Investor's Business Daily - Wed Nov 19, 6:01PM CST
The specialty drugmaker's Q4 EPS jumped 71% to $1.68, beating views by 27 cents. Sales rose 45% to $789 mil, also topping. A Leerink analyst attributed the beat to cost controls and strength in the specialty generics business. But last week the FDA...
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31)
Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy
at Investor's Business Daily - Wed Nov 19, 4:35PM CST
Specialty drugmaker Mallinckrodt early Wednesday beat analysts' expectations handily with its fiscal Q4 report, but the stock fell 3.2% after the company put off providing hoped-for guidance in the wake of a Food and Drug Administration decision that...
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31), ACT: 254.20 (-1.68)
Mallinckrodt's (MNK) CEO Mark Trudeau on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 19, 1:19PM CST
MNK: 97.84 (-0.29)
Endo and BioDelivery Sciences submit NDA for transmucosal pain med
Seeking Alpha - at Seeking Alpha - Thu Dec 25, 11:41AM CST
MNK: 97.84 (-0.29), BDSI: 12.65 (+0.66), ENDP: 72.10 (+0.34), EGLT: 5.97 (+0.21), ZGNX: 1.20 (+0.04), PFE: 31.42 (-0.03), TEVA: 57.09 (+0.33), ABBV: 66.21 (+1.86), ALKS: 56.16 (+1.02), ACUR: 0.52 (+0.02)
Insider Trading Alert - FNGN, PGR And MNK Traded By Insiders
at The Street - Wed Dec 24, 10:33AM CST
Stocks with insider trader activity include FNGN, PGR and MNK
MNK: 97.84 (-0.29), PGR: 26.92 (-0.05), FNGN: 37.85 (+0.79)
Mallinckrodt to Present at J.P. Morgan Healthcare Conference January 12
Business Wire - Mon Dec 22, 4:00PM CST
Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, will present at the 33rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis on Union Square in San Francisco on Monday, January 12, 2015. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 3 p.m. Pacific/6 p.m. Eastern.
MNK: 97.84 (-0.29), JPM: 62.48 (unch)
5 Health Care Stocks John Paulson Is Buying Ahead of 2015
at The Street - Mon Dec 22, 6:00AM CST
Here's a closer look at five stocks Paulson & Co. bought in the most recently reported quarter.
MNK: 97.84 (-0.29), HCA: 74.89 (-0.11), COV: 103.35 (+0.57), MYL: 56.97 (+0.39), ABBV: 66.21 (+1.86)
Baidu, Alibaba Among Top World Stocks Building Bases
at Investor's Business Daily - Thu Dec 18, 5:09PM CST
This is the time when investors should be building watch lists, and the Top World Stocks list offers a range of possible candidates. Three stocks on the list (to the right), Avago Technologies (AVGO), Cimpress (CMPR) and Radware (RDWR), are clearly...
MNK: 97.84 (-0.29), RDWR: 22.18 (+0.24), ACT: 254.20 (-1.68), BIDU: 230.98 (-2.18), HDB: 50.86 (-0.06), CMPR: 75.76 (+0.05), NXPI: 76.75 (+0.48), AVGO: 100.72 (-0.06), BABA: 105.95 (+0.43)
Great Stocks: Mallinckrodt Rebounds, But Is It A Buy?
at Investor's Business Daily - Thu Dec 18, 5:09PM CST
Specialty drugmaker Mallinckrodt (MNK) has rebounded off its 10-week moving average for the third time since it broke out of a cup base in early September. But should investors buy the bounce? Mallinckrodt cleared an 83.30 cup-base buy point Sept. 3...
MNK: 97.84 (-0.29), COV: 103.35 (+0.57)
Top Healthcare Stocks for 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Dec 14, 10:03AM CST
Source: Flickr user Tax Credits . This past year has been a great one for healthcare investors -- the S&P healthcare index ETF offered double the return of the S&P 500. Biotechnology stocks dominated the list of the 10 top-performing...
MNK: 97.84 (-0.29), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), AGN: 210.12 (+0.95), VRTX: 115.15 (+1.40), ALNY: 93.52 (+0.97), EW: 130.75 (+1.17), ILMN: 186.22 (+2.72), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07), PBYI: 189.96 (+0.12)
Top Global Stocks: Jazz, Actavis In IBD's World List
at Investor's Business Daily - Mon Dec 08, 5:39PM CST
Three top-ranked drugmakers are among IBD's 10 leading global growth stocks. One is in buying range. Jazz Pharmaceuticals (JAZZ) appears to have gained some traction after a disappointing breakout Nov. 5, when the stock cleared its buy point only to...
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31), ACT: 254.20 (-1.68), COV: 103.35 (+0.57), JAZZ: 165.33 (+1.83)
Great Stocks: Mallinckrodt Buys Raise Profit Margins
at Investor's Business Daily - Thu Dec 04, 5:20PM CST
Mallinckrodt has been active in its brief run as a public company. The specialty pharmaceuticals firm debuted in July 2013 after being spun off from Covidien (COV). Two major acquisitions -- Questcore Pharmaceuticals, finalized in August, and Cadence...
MNK: 97.84 (-0.29), ACT: 254.20 (-1.68), COV: 103.35 (+0.57)
Pain Therapeutics' Remoxy Would Be A Good Fit For Any Of These Experienced Companies
Clinically Sound Investor - at Seeking Alpha - Wed Dec 03, 2:41PM CST
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31), ENDP: 72.10 (+0.34), ACT: 254.20 (-1.68), DRRX: 0.81 (-0.01), NVS: 93.91 (+0.66), PTIE: 2.01 (-0.02)
Mallinckrodt to Present at Piper Jaffray 26th Annual Healthcare Conference in New York
Business Wire - Mon Dec 01, 3:45PM CST
Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical and global medical imaging company, will present at the Piper Jaffray 26th Annual Healthcare Conference in New York on Wednesday, December 3, 2014. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the company in a session scheduled to begin at 11 a.m. Eastern.
MNK: 97.84 (-0.29)
Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Mallinckrodt, and Actavis
PR Newswire - Tue Nov 25, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), Zoetis Inc. (NYSE: ZTS), Allergan Inc. (NYSE: AGN), Mallinckrodt PLC (NYSE: MNK), and Actavis PLC (NYSE: ACT). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 24, 2014, the NASDAQ Composite ended at 4,754.89, up 0.89%, the Dow Jones Industrial Average advanced 0.04%, to finish the day at 17,817.90, and the S&P 500 closed at 2,069.41, up 0.29%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 792.85, up 0.47%, with the index also advancing 9.00% in the previous three months. Register for your complimentary reports on these five stocks at:
MNK: 97.84 (-0.29), AGN: 210.12 (+0.95), ZTS: 43.84 (+0.87), ACT: 254.20 (-1.68), AVNR: 16.91 (+0.01)
Alibaba: The Top New Position For Hedge Funds
ValueWalk - at Seeking Alpha - Fri Nov 21, 2:24PM CST
MNK: 97.84 (-0.29), EBAY: 57.10 (-0.12), SHPG: 209.29 (+0.07), ABBV: 66.21 (+1.86), AAPL: 112.01 (-0.53), BABA: 105.95 (+0.43)
10 Stocks Billionaire John Paulson Loves in 2014
at The Street - Fri Nov 21, 7:56AM CST
Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.
MNK: 97.84 (-0.29), HCA: 74.89 (-0.11), EQIX: 233.16 (+1.18), SHPG: 209.29 (+0.07), COV: 103.35 (+0.57), DTV: 86.82 (-0.05), MYL: 56.97 (+0.39), ABBV: 66.21 (+1.86), TWC: 151.15 (+0.17), CIE: 8.79 (-0.25)
FDA clears Purdue's abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 12:36PM CST
MNK: 97.84 (-0.29), EGLT: 5.97 (+0.21), ZGNX: 1.20 (+0.04), PFE: 31.42 (-0.03), TEVA: 57.09 (+0.33), ABBV: 66.21 (+1.86), ALKS: 56.16 (+1.02), ACUR: 0.52 (+0.02)
Tracking John Paulson's Paulson & Company Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Thu Nov 20, 12:49AM CST
RKT: 61.26 (-0.41), KOG: 6.56 (-0.39), MEAS: 86.00 (+0.01), HHC: 133.21 (+0.49), AET: 89.59 (+0.14), DLPH: 73.45 (-0.42), DLTR: 69.86 (-0.20), AEM: 23.65 (+0.65), AUXL: 34.40 (+0.18), DG: 69.86 (+0.31), ABBV: 66.21 (+1.86), DXM: 9.06 (+0.12), MNK: 97.84 (-0.29), ATHL: 58.40 (unch), NCQ: 0.55 (unch), COV: 103.35 (+0.57), AU: 8.39 (+0.24), MYL: 56.97 (+0.39), IAG: 2.41 (+0.06), FDO: 79.14 (-0.01), MGM: 20.77 (-0.17), GNW: 8.40 (+0.01), HIG: 42.13 (-0.12), NG: 2.82 (+0.10), EQIX: 233.16 (+1.18), HSH: 62.96 (unch), OAS: 16.66 (-1.05), PETM: 81.16 (+0.03), ACT: 254.20 (-1.68), MDT: 74.08 (+0.31), BPOP: 33.68 (+0.09), ENZY: 7.48 (-0.01), FCX: 22.91 (+0.07), GFI: 4.37 (+0.13), CZR: 15.44 (+0.20), CVC: 20.60 (+0.17), CIE: 8.79 (-0.25), CACQ: 9.96 (+0.12), AGN: 210.12 (+0.95), ECA: 13.73 (-0.03), FCH: 10.80 (-0.06), R: 93.37 (-0.15), DTV: 86.82 (-0.05), KMDA: 3.57 (-0.03), ANV: 0.88 (+0.02), MOVE: 20.95 (-0.03), BAC: 17.98 (+0.05), GRFS: 34.26 (+0.33), POST: 42.51 (+0.49), HCA: 74.89 (-0.11), RDN: 16.78 (+0.18), BEE: 13.55 (-0.01), CPWR: 10.35 (+0.01), GLD: 112.77 (+0.03), RLGY: 43.91 (+0.39), MTG: 9.31 (+0.06), HMHC: 20.75 (-0.03), CMCSA: 58.07 (+0.17), CBS: 55.70 (-0.13), BABA: 105.95 (+0.43)
Mallinckrodt tops, no outlook
at Investor's Business Daily - Wed Nov 19, 6:01PM CST
The specialty drugmaker's Q4 EPS jumped 71% to $1.68, beating views by 27 cents. Sales rose 45% to $789 mil, also topping. A Leerink analyst attributed the beat to cost controls and strength in the specialty generics business. But last week the FDA...
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31)
Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy
at Investor's Business Daily - Wed Nov 19, 4:35PM CST
Specialty drugmaker Mallinckrodt early Wednesday beat analysts' expectations handily with its fiscal Q4 report, but the stock fell 3.2% after the company put off providing hoped-for guidance in the wake of a Food and Drug Administration decision that...
MNK: 97.84 (-0.29), JNJ: 104.59 (+0.31), ACT: 254.20 (-1.68)
Mallinckrodt's (MNK) CEO Mark Trudeau on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 19, 1:19PM CST
MNK: 97.84 (-0.29)
